Shifali Shishodia

Dr. Shifali Shishodia

Medical College of Wisconsin
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 December 2021 in Nature Chemistry
Verified
Journal Article
Closed access
PDF file
JBJurgen Brem
Jurgen Brem
TPTharindi Panduwawala
Tharindi Panduwawala
JHJon Ulf Hansen
Jon Ulf Hansen
JHJoanne Hewitt
Joanne Hewitt
ELEdgars Liepins
Edgars Liepins
CSChristopher J. Schofield
Christopher J. Schofield

16 May 2018 in Organic & Biomolecular Chemistry
Verified
Journal Article
Open access
PDF file
SSShifali Shishodia
Shifali Shishodia
DZD. Zhang
D. Zhang
AEA. H. El-Sagheer
A. H. El-Sagheer
TBT. Brown
T. Brown
TCT. D. W. Claridge
T. D. W. Claridge
RHR. J. Hopkinson
R. J. Hopkinson
Formaldehyde is produced in cells by enzyme-catalysed demethylation reactions, including those occurring on N-methylated nucleic acids. Formaldehyde reacts with nucleobases to form N-hydroxymethylated adducts that may contribute to its toxicity/carcinogenicity when added exogenously, but the chemistry of these reactions has been incompletely defined. We report NMR studies on the reactions of formaldehyde with canonical/modified nucleobases. The results reveal that hydroxymethyl hemiaminals on endocyclic nitrogens, as observed with thymidine and uridine monophosphates, are faster to form than equivalent hemiaminals on exocyclic nitrogens; however, the exocyclic adducts, as formed with adenine, guanine and cytosine, are more stable in solution. Nucleic acid demethylase (FTO)-catalysed hydroxylation of (6-methyl)adenosine results in (6-hydroxymethyl)adenosine as the major observed product; by contrast no evidence for a stable 3-hydroxymethyl adduct was accrued with FTO-catalysed oxidation of (3-methyl)thymidine. Collectively, our results imply N-hydroxymethyled adducts of nucleic acid bases, formed either by reactions with formaldehyde or via demethylase catalysis, have substantially different stabilities, with some being sufficiently stable to have functional roles in disease or the regulation of nucleic acid/nucleobase activity.

13 October 2022 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
SSShifali Shishodia
Shifali Shishodia
RNRaymundo Nuñez
Raymundo Nuñez
BSBrayden P. Strohmier
Brayden P. Strohmier
KBKarina L. Bursch
Karina L. Bursch
CGChristopher J. Goetz
Christopher J. Goetz
Brian Christopher SmithBrian Christopher Smith
Brian Christopher Smith

31 December 2020 in Molecules
Verified
Journal Article
Open access
PDF file
SSShifali Shishodia
Shifali Shishodia
CSChristopher J. Schofield
Christopher J. Schofield
N6-methyladenosine(m6A) is the most abundant modification in mRNA. Studies on proteins that introduce and bind m6A require the efficient synthesis of oligonucleotides containing m6A. We report an improved five-step synthesis of the m6A phosphoramidite starting from inosine, utilising a 1-H-benzotriazol-1-yloxytris(dimethylamino)phosphoniumhexafluorophosphate (BOP)-mediated SNAr reaction in the key step. The route manifests a substantial increase in overall yield compared to reported routes, and is useful for the synthesis of phosphoramidites of other adenosine derivatives, such as ethanoadenosine, an RNA analogue of the DNA adduct formed by the important anticancer drug Carmustine.

27 August 2025 in Nucleic Acids Research
Verified
Journal Article
Open access
SKSimranjeet Kaur
Simranjeet Kaur
PMPratheesh Maheswaran
Pratheesh Maheswaran
SKSamanpreet Kaur
Samanpreet Kaur
YLYingqi Lai
Yingqi Lai
ESEidarus Salah
Eidarus Salah
WAWei Shen Aik
Wei Shen Aik
N 6-Methyladenosine (m6A) is a prevalent post-transcriptional modification in eukaryotic messenger RNA. Two cancer-linked human Fe(II) and 2-oxoglutarate (2OG)-dependent oxygenases, the fat mass and obesity associated-protein (FTO), and AlkB human homolog 5 (ALKBH5) catalyse m6A methyl group oxidation. While ALKBH5 has consistently been reported to catalyse m6A demethylation, there are conflicting reports concerning the FTO products. We report studies using mass spectrometry and nuclear magnetic resonance comparing products of FTO, ALKBH5, and DNA damage repair demethylases (human ALKBH2 and ALKBH3 and bacterial AlkB, using m1A single-stranded DNA substrates). The results with m6A-containing single-stranded RNA (ssRNA) and N6,2′-O-dimethyladenosine adjacent to the 5′ m7G triphosphate cap ssRNA substrates imply that the predominant FTO product is N6-hydroxymethyladenosine, either with or without methylation on the substrate ribose 2′-hydroxyl group. The nascent hemiaminal product undergoes relatively slow non-enzyme catalysed fragmentation giving adenosine/formaldehyde. The other four 2OG-dependent oxygenases tested, including ALKBH5, produce demethylated bases as the predominant products. The results imply that, at least in isolated form, FTO preferentially acts as a hydroxylase, producing a hemiaminal product, rather than a demethylase, distinguishing it from ALKBH5. They highlight a need for investigations into the roles of hemiaminal-type modifications to nucleic acids, in both healthy biology and disease.

16 September 2025 in ACS Medicinal Chemistry Letters
Verified
Journal Article
Closed access
RNRaymundo Nuñez
Raymundo Nuñez
KBKarina L. Bursch
Karina L. Bursch
SMSavannah J. Makowski
Savannah J. Makowski
MXMingguang Xue
Mingguang Xue
KCKira A. Cozzolino
Kira A. Cozzolino
Brian Christopher SmithBrian Christopher Smith
Brian Christopher Smith